Wissel J - Search Results

1

Interventional neuropediatrics: treatment of dystonic and spastic muscular hyperactivity with botulinum toxin A.

Heinen F, Wissel J, Philipsen A, Mall V, Leititis JU, Schenkel A, Stücker R, Korinthenberg R. Heinen F, et al. Among authors: wissel j. Neuropediatrics. 1997 Dec;28(6):307-13. doi: 10.1055/s-2007-973721. Neuropediatrics. 1997. PMID: 9453027 Clinical Trial.

2

Use of botulinum toxin in the treatment of cervical dystonia.

Poewe W, Wissel J. Poewe W, et al. Among authors: wissel j. Baillieres Clin Neurol. 1993 Apr;2(1):179-85. Baillieres Clin Neurol. 1993. PMID: 8143072 Review.

3

Botulinum toxin in writer's cramp: objective response evaluation in 31 patients.

Wissel J, Kabus C, Wenzel R, Klepsch S, Schwarz U, Nebe A, Schelosky L, Scholz U, Poewe W. Wissel J, et al. J Neurol Neurosurg Psychiatry. 1996 Aug;61(2):172-5. doi: 10.1136/jnnp.61.2.172. J Neurol Neurosurg Psychiatry. 1996. PMID: 8708685 Free PMC article. Clinical Trial.

4

Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor.

Wissel J, Masuhr F, Schelosky L, Ebersbach G, Poewe W. Wissel J, et al. Mov Disord. 1997 Sep;12(5):722-6. doi: 10.1002/mds.870120516. Mov Disord. 1997. PMID: 9380055 Clinical Trial.

5

What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group.

Poewe W, Deuschl G, Nebe A, Feifel E, Wissel J, Benecke R, Kessler KR, Ceballos-Baumann AO, Ohly A, Oertel W, Künig G. Poewe W, et al. Among authors: wissel j. J Neurol Neurosurg Psychiatry. 1998 Jan;64(1):13-7. doi: 10.1136/jnnp.64.1.13. J Neurol Neurosurg Psychiatry. 1998. PMID: 9436721 Free PMC article. Clinical Trial.

6

[Psychosomatic aspects of idiopathic spasmodic torticollis. Results of a multicenter study].

Scheidt CE, Rayki O, Nickel T, Heinen F, Wissel J, Poewe W, Benecke R, Arnold G, Oertel W, Dengler R, Deuschl G. Scheidt CE, et al. Among authors: wissel j. Psychother Psychosom Med Psychol. 1998 Jan;48(1):1-12. Psychother Psychosom Med Psychol. 1998. PMID: 9499714 Review. German.

7

Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of "high-dose" versus "low-dose" treatment.

Wissel J, Heinen F, Schenkel A, Doll B, Ebersbach G, Müller J, Poewe W. Wissel J, et al. Neuropediatrics. 1999 Jun;30(3):120-4. doi: 10.1055/s-2007-973475. Neuropediatrics. 1999. PMID: 10480205 Clinical Trial.

8

[Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].

Wissel J, Müller J, Heinen F, Mall V, Sojer M, Ebersbach G, Poewe W. Wissel J, et al. Wien Klin Wochenschr. 1999 Oct 29;111(20):837-42. Wien Klin Wochenschr. 1999. PMID: 10586488 Clinical Trial. German.

9

Recommendations for the use of botulinum toxin type A in the management of cerebral palsy.

Graham HK, Aoki KR, Autti-Rämö I, Boyd RN, Delgado MR, Gaebler-Spira DJ, Gormley ME, Guyer BM, Heinen F, Holton AF, Matthews D, Molenaers G, Motta F, García Ruiz PJ, Wissel J. Graham HK, et al. Among authors: wissel j. Gait Posture. 2000 Feb;11(1):67-79. doi: 10.1016/s0966-6362(99)00054-5. Gait Posture. 2000. PMID: 10664488 Review.

10

Management of spasticity associated pain with botulinum toxin A.

Wissel J, Müller J, Dressnandt J, Heinen F, Naumann M, Topka H, Poewe W. Wissel J, et al. J Pain Symptom Manage. 2000 Jul;20(1):44-9. doi: 10.1016/s0885-3924(00)00146-9. J Pain Symptom Manage. 2000. PMID: 10946168 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters